Modern antiplatelet agents in coronary artery disease.

about

Role of Pannexin-1 hemichannels and purinergic receptors in the pathogenesis of human diseases.

P2860

Q37636397-BC74ACD1-4DD3-4AEF-A620-1776A0CDF4FE

P2860

Modern antiplatelet agents in coronary artery disease.

Item

http://www.wikidata.org/entity/Q38063289

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Modern antiplatelet agents in coronary artery disease.

@en

type

Item

label

Modern antiplatelet agents in coronary artery disease.

@en

prefLabel

Modern antiplatelet agents in coronary artery disease.

@en

P1476

Modern antiplatelet agents in coronary artery disease.

@en

P2093

Brian G Hynes

http://www.w3.org/2001/XMLSchema#string

Darragh Moran

http://www.w3.org/2001/XMLSchema#string

Gary Kiernan

http://www.w3.org/2001/XMLSchema#string

Hatim Yagoub

http://www.w3.org/2001/XMLSchema#string

Nicholas J Ruggiero

http://www.w3.org/2001/XMLSchema#string

Rachel F Power

http://www.w3.org/2001/XMLSchema#string

Thomas J Kiernan

http://www.w3.org/2001/XMLSchema#string

P2860

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin

Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment

Pharmacology of CS-747 (prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activity

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study

Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease

Safety profile and tolerability of intravenous AR-C69931MX, a new antiplatelet drug, in unstable angina pectoris and non-Q-wave myocardial infarction

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

P304

1261-1272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1586/ERC.12.127

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23190065

http://www.w3.org/2001/XMLSchema#string

Modern antiplatelet agents in coronary artery disease.

about

P2860

P2860

Modern antiplatelet agents in coronary artery disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698